88 filings
Page 2 of 5
8-K
eq4 l98c5x3t3ra27wr
11 Aug 22
UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
8:11am
8-K
5apbpx
13 Jun 22
Departure of Directors or Certain Officers
4:55pm
8-K
dg7uo23jr47fmbk
10 May 22
UroGen Pharma Reports First Quarter 2022 Financial Results
9:11am
8-K
3cdy 775umokz5
21 Mar 22
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results
8:11am
8-K
h7cbkwf4k01yddm 3f
8 Mar 22
Entry into a Material Definitive Agreement
9:13am
8-K
2h3actaf
15 Nov 21
UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
8:10am
8-K
imz 7irsdbphrzt9
10 Nov 21
Other Events
5:08pm
8-K
9fp5p991kt1ffj9y0ti
13 Sep 21
Other Events
8:15am
8-K
rnim8f1sf
4 Aug 21
UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate
8:11am
8-K
xl5dr
14 Jul 21
UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021
8:11am
8-K
c72x g6hwseird
8 Jun 21
Departure of Directors or Certain Officers
2:43pm
8-K
sap8gkoorvrr9b rz
13 May 21
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
7:40am
8-K
72t9p7c80 947alcy4
18 Mar 21
UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
8:13am
8-K
uibzaes f6wh5psln1
18 Mar 21
UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
8:10am
8-K
q9708r yjnxzkt
13 Jan 21
Other Events
8:03am
8-K
qp25 dveu
11 Jan 21
Regulation FD Disclosure
8:31am
8-K
fld p7cl1licf
3 Dec 20
Other Events
4:05pm
8-K
xr50wx
17 Nov 20
Other Events
4:15pm
8-K
49kcutytac8m7f4ed q5
9 Nov 20
UroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
8:13am
8-K
cgl5q9
9 Sep 20
Departure of Directors or Certain Officers
8:02am